Literature DB >> 28050629

Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

George F Koob1.   

Abstract

RATIONALE AND
OBJECTIVES: Addiction is defined as a chronically relapsing disorder characterized by compulsive drug seeking that is hypothesized to derive from multiple sources of motivational dysregulation. METHODS AND
RESULTS: Dr. Athina Markou made seminal contributions to our understanding of the neurobiology of addiction with her studies on the dysregulation of reward function using animal models with construct validity. Repeated overstimulation of the reward systems with drugs of abuse decreases reward function, characterized by brain stimulation reward and presumbably reflecting dysphoria-like states. The construct of negative reinforcement, defined as drug taking that alleviates a negative emotional state that is created by drug abstinence, is particularly relevant as a driving force in both the withdrawal/negative affect and preoccupation/anticipation stages of the addiction cycle.
CONCLUSIONS: The negative emotional state that drives such negative reinforcement is hypothesized to derive from the dysregulation of key neurochemical circuits that drive incentive-salience/reward systems (dopamine, opioid peptides) in the ventral striatum and from the recruitment of brain stress systems (corticotropin-releasing factor, dynorphin) within the extended amygdala. As drug taking becomes compulsive-like, the factors that motivate behavior are hypothesized to shift to drug-seeking behavior that is driven not only by positive reinforcement but also by negative reinforcement. This shift in motivation is hypothesized to reflect the allostatic misregulation of hedonic tone such that drug taking makes the hedonic negative emotional state worse during the process of seeking temporary relief with compulsive drug taking.

Entities:  

Keywords:  Addiction; Brain stimulation reward; Corticotropin-releasing factor; Dependence; Drug Abuse; Dynorphin; Intracranial self-stimulation; Negative reinforcement

Mesh:

Substances:

Year:  2017        PMID: 28050629     DOI: 10.1007/s00213-016-4484-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  144 in total

1.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

Review 2.  Molecular and cellular aspects of nicotine abuse.

Authors:  J A Dani; S Heinemann
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

Review 3.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

4.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

5.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

6.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

Review 7.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

8.  The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.

Authors:  P Adamczyk; A C McCreary; E Przegalinski; P Mierzejewski; P Bienkowski; M Filip
Journal:  J Physiol Pharmacol       Date:  2009-09       Impact factor: 3.011

9.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

10.  Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.

Authors:  Maria Scherma; Leigh V Panlilio; Paola Fadda; Liana Fattore; Islam Gamaleddin; Bernard Le Foll; Zuzana Justinová; Eva Mikics; Jozsef Haller; Julie Medalie; Jessica Stroik; Chanel Barnes; Sevil Yasar; Gianluigi Tanda; Daniele Piomelli; Walter Fratta; Steven R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-08-25       Impact factor: 4.030

View more
  19 in total

1.  In Memory of Athina Markou (1961-2016): Obituary.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2017-05       Impact factor: 4.530

Review 2.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

3.  Affective Disturbances During Withdrawal from Chronic Intermittent Ethanol Inhalation in C57BL/6J and DBA/2J Male Mice.

Authors:  Harpreet Sidhu; Max Kreifeldt; Candice Contet
Journal:  Alcohol Clin Exp Res       Date:  2018-05-21       Impact factor: 3.455

4.  Co-Occurring Obsessive-Compulsive Disorder and Compulsive Sexual Behavior: Clinical Features and Psychiatric Comorbidities.

Authors:  Lindsey A Snaychuk; Ygor A Ferrão; Leonardo F Fontenelle; Euripedes C Miguel; Maria A de Mathis; Marco D T Scanavino; Hyoun S Kim
Journal:  Arch Sex Behav       Date:  2022-09-06

5.  Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.

Authors:  Brendan J Tunstall; Chelsea P Ho; Jianjing Cao; Janaína C M Vendruscolo; Brooke E Schmeichel; Rachel D Slack; Gianluigi Tanda; Alexandra J Gadiano; Rana Rais; Barbara S Slusher; George F Koob; Amy H Newman; Leandro F Vendruscolo
Journal:  Neuropharmacology       Date:  2017-12-05       Impact factor: 5.250

Review 6.  Drug addiction: a curable mental disorder?

Authors:  Jian-Feng Liu; Jun-Xu Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

7.  The effects of acute stress on consummatory and motivational responses for sucrose in rats after long-term withdrawal from morphine.

Authors:  Yunjing Bai; Yue Zhang; Shaofei Jiang; Xigeng Zheng; Zhengkui Liu
Journal:  Psychopharmacology (Berl)       Date:  2019-07-12       Impact factor: 4.530

8.  Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration.

Authors:  Sam A McConnell; Adam J Brandner; Brandon A Blank; David N Kearns; George F Koob; Leandro F Vendruscolo; Brendan J Tunstall
Journal:  Neuropharmacology       Date:  2020-10-20       Impact factor: 5.250

9.  N6-substituated adenosine analog J4 attenuates anxiety-like behaviors in mice.

Authors:  Lee Peyton; Brandon Emanuel León; Hesham Essa; Yijuang Chern; Doo-Sup Choi
Journal:  Psychopharmacology (Berl)       Date:  2022-01-31       Impact factor: 4.415

Review 10.  Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.

Authors:  George F Koob
Journal:  Curr Top Behav Neurosci       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.